Thank you, Doug. Good morning, everyone. Thanks for joining us. Our second quarter results reflect an increase in net interest margin, a loan portfolio that remains 100% fine and the decline in our CECL reserve of $4.5 million or 6.1%, reflecting $186.1 million of loan repayments, along with solid operating performance of our loan collateral. GAAP net income attributable to common shareholders was $21 million as compared to $13.1 million in the preceding quarter. That increase was due almost entirely to a quarter-over-quarter reduction in credit loss expense of $8.9 million, driven by a $4.5 million reduction in our CECL reserve for the second quarter, compared to a $4.4 million increase in the first quarter of this year. Net interest margin for our loan portfolio was $27.5 million versus $26.8 million in the prior quarter or $0.01 per common share due to reduced borrowings and further optimization of our liability structure. Our weighted average credit spread on borrowings was virtually unchanged at 197 basis points. Distributable earnings were $22.3 million or $0.28 per share. Coverage in the quarter for the quarter of our $0.24 dividend was 1.17 times and 1.21 times for the first six months of this year. Our CECL reserve declined by $4.5 million to $69.6 million from $74.1 million, or $0.06 per share. This decline was due primarily to solid collateral operating performance and a quarter-over-quarter net decline in UPB of $168 million. All of our loans were current. We had no five rated loans more specifically identified loans, thus we had no specific CECL loan loss reserve. Our CECL reserve was 208 basis points versus 210 basis points last quarter. We incurred no realized losses in the quarter. Book value declined $0.41 per share to $11.40 from $11.81, reflecting the net impact of, first, distributable earnings per share, exceeding our dividend by $0.04. Second, the $0.06 per share reduction in our CECL reserve; and third, a $0.39 per share decline due to the delivery on May 8 of 2.6 million common shares of TRTX relating to a warrant exercise. No warrants remain outstanding. Regarding our loan investment portfolio. Multifamily now represents 52.5% of our loan portfolio. Office has declined 73% over the past 10 quarters to 18.4%. Life Sciences 12.1%, Hotels 10.4%, and no other property type comprises more than 3.4% of our book. Office loan UPB declined by $95.8 million, representing 51.5% of total loan repayments received during the second quarter. That was due primarily to the par repayment in full of two office loans, one in Atlanta and the other in the Mid [indiscernible] submarket of the Bay Air. At quarter end, total office UPB was $587.5 million across six of our 48 loan investments. We had no new loan originations during the quarter, but we did close on July 3 at $96 million first mortgage loan on a two-property portfolio of leased multifamily, whose closing split from the last week of June to the first week of July. Our sizable pipeline is populated with quality transactions that fit our strike zone. Regarding REO, we have five REO properties comprising 5.2% of our total assets. One multifamily property and four office properties with a total carrying value of $190.4 million. Using the depth and breadth of TPG Real Estate platform, we continue to drive operating performance and finalize near-term disposition strategies for properties that would otherwise require significant capital investment and longer hold periods. This portfolio currently contributes $0.04 per share to our distributable earnings. Please refer to Note 4 of our financial statements for a snapshot of our REO portfolio. Regarding credit, our weighted average risk rating was unchanged at 3.0. All of our loans were current refer to Page 53 of our 10-Q for more detail. Regarding liabilities and capital base, the share of non-mark-to-market, non-recourse term financing increased at quarter end to 78.7% from 77.1% at March 31. Total leverage declined to 2:1 from 2.2:1 at March 31. We have $4.1 billion of total financing capacity across 11 different arrangements. In June, we opted to terminate rather than renew a $500 million secured credit facility with Morgan Stanley due to nonuse. We repaid $1.8 million of borrowings upon termination. Liquidity and pricing in the market continue to improve for financing provided to non-direct lending from large and mid-sized banks. Combined with unchanged to slightly wider loan spreads on new loan investments, our ROEs are stable to improve. We completed in April, the reinvestment of the final $51 million of cash in our FL5 CLO. The reinvestment windows are now closed for all three of our CLOs, although we remain able to substitute and exchange loans under certain circumstances. We continue to monitor the CRE CLO market as a tool to further optimize our cost-efficient, highly non-mark-to-market liability structure, either refinancing existing CLOs, financing loan investments that are currently unencumbered or to finance new loan investments. Presently, the one on note market continues to hold greater appeal to us due to more favorable structure and money terms. We were in compliance with all of our financial covenants at June 30, 2024. We repurchased no shares during the second quarter under our share repurchase program, largely because our share price appreciated by 11.9% during the quarter. TRTX share price appreciation was 41.2% for the first six months of this year. We maintain an appropriate amount of intermediate immediate and near-term liquidity at 10.5% of our total asset base. Cash and near-term liquidity was $389.4 million at June 30, compared to $370.7 million at March 31, comprised of $244.2 million of cash in excess of our covenant requirements and $127.7 million of undrawn capacity under our secured credit agreements. During the quarter, we funded $18.1 million of commitments under existing loans. At quarter end, our deferred funding obligations under existing loan agreements totaled only $139.6 million, nearly 4.2% of our total loan commitments and less than half of our current liquidity. In summary, the second quarter was characterized by strong operating performance, solid credit, further optimization of our liability structure and significant liquidity to support opportunistic capital allocation. And with that, we'll open the floor to questions. Operator?